Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 109631
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109631
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109631
Table 1 Incidence of postoperative pulmonary complications in this study
PPCs | n | Ratio (n/total number of patients),% |
Pleural effusion | 41 | 52.56% |
Respiratory infection | 34 | 43.59% |
Respiratory failure | 10 | 12.82% |
Atelectasis | 10 | 12.82% |
Pneumothorax | 2 | 2.56% |
Bronchospasm | 1 | 1.28% |
Aspiration pneumonia | 0 | 0 |
Table 2 Comparison of baseline characteristics between the non-postoperative pulmonary complication and postoperative pulmonary complication groups, n (%)
Variable | PPC (n = 78) | Non-PPC (n = 234) | P value |
Demographics | |||
Sex (male) | 56 (71.2) | 145(62.0) | 0.116 |
Age (years) | 59 (24-90) | 56 (23-87) | 0.03 |
Height (cm) | 167 (145-185) | 167 (150-185) | 0.663 |
Weight (kg) | 63 (36.5-95) | 64 (37-99) | 0.688 |
BMI (kg/m2) | 22.6 (16.22, 34.67) | 23.0 (14.6, 38.11) | 0.279 |
Preoperative status | |||
Smoking | 8 (10) | 26 (11) | 0.834 |
Pathogenic colonization bacteria | 11 (14.1) | 18 (7.7) | 0.091 |
Hemoglobin, mean ± SD | 144.49 ± 23.13 | 119.68 ± 24.61 | 0.102 |
Platelet, mean ± SD | 180.53 ± 86.59 | 196.06 ± 100.36 | 0.222 |
Albumin (g/L), mean ± SD | 34.30 ± 5.52 | 37.88 ± 6.71 | < 0.001 |
TBIL (μmol/L) | 17.75 (4.0-504.9) | 13.8 (2.5-476.3) | 0.038 |
DBIL (μmol/L) | 11.4 (1.7-507) | 6.6 (1.6-401.2) | 0.002 |
AST (U/L) | 43.35 (10.10-3421.10) | 29 (9.4-3435.4) | 0.002 |
ALT (U/L) | 41.95 (5.6-1617.4) | 24.8 (5.0-2004.9) | 0.003 |
Comorbidities | |||
Hypertension | 24 (30.8) | 62 (26.5) | 0.464 |
Diabetes mellitus | 0 | 29 (12.4) | 0.001 |
HBV infection | 18 (23.1) | 48 (20.5) | 0.631 |
Liver cirrhosis | 10 (12.8) | 40 (17.1) | 0.373 |
Heart failure | 1 (1.3) | 2 (0.9) | 0.738 |
History of stroke | 1 (1.3) | 13 (5.5) | 0.114 |
COPD | 0 | 5 (2.13) | 0.193 |
Table 3 Intraoperative and postoperative factors in the non-postoperative pulmonary complication and postoperative pulmonary complication groups, n (%)
Variable | PPC (n = 78) | Non-PPC (n = 234) | P value |
Intraoperative factors | |||
ASA physical status | |||
III-IV | 34 (43.59) | 51 (21.8) | < 0.001 |
Operation duration ≥ 2 hours | 45 (57.7) | 78 (33.3) | < 0.001 |
Anesthesia duration (10 minutes) | 572.18 ± 226.41 | 252.98 ± 222.71 | < 0.001 |
Estimated blood loss ≥ 100 mL | 38 (48.7) | 38(16.2) | < 0.001 |
Blood transfusion | 19 (24.4) | 11 (4.7) | < 0.001 |
Infusion (mL) | 4550.16 ± 2239.36 | 2320.70 ± 1957.34 | < 0.001 |
Surgical procedure | |||
Interventional surgery (percutaneous arterial embolization/angiography/catheterization) | 34 (43.6) | 110 (47.0) | 0.6 |
Liver surgery (liver segment/partial resection) | 25 (32.1) | 76 (32.48) | 0.944 |
Laparoscopic surgery (gallbladder/Liver/intestine) | 8 (10.25) | 29 (12.39) | 0.613 |
Other operations | 7 (9.0) | 15 (6.4) | 0.444 |
Pancreatic surgery | 4 (5.1) | 4 (1.7) | 0.098 |
Postoperative factors | |||
Pain (NRS score ≥ 1) | 1 (1.3) | 13 (5.5) | 0.114 |
Poor drainage | 1 (1.3) | 0 | 0.083 |
Table 4 Hospital length of stays and healthcare cost burden among patients
Group | All patients | LOS (days) [median (P25, P75)] | Postoperative hospital stays (days) [median (P25, P75)] | Total cost (10000 yuan)1 [median (P25, P75)] | Medication costs (10000 yuan)1 [median (P25, P75)] |
PPCs | 78 | 15 (8, 21) | 11 (6, 17) | 12.19 (5.34, 20.06) | 2.25 (1.00, 4.96) |
Non-PPCs | 234 | 7 (4, 12) | 3 (1, 7) | 3.22 (2.02, 6.81) | 0.75 (0.17, 1.63) |
Z value | - | -5.957 | -7.662 | -7.044 | -6.550 |
P value | - | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Meng HJ, Chen ZH, Nie GM, Ji ZS, Wang YJ, Hu YF, Tang J. Epidemiology and risk of pulmonary complications following hepatobiliary surgical procedures: A retrospective study. World J Gastrointest Surg 2025; 17(9): 109631
- URL: https://www.wjgnet.com/1948-9366/full/v17/i9/109631.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i9.109631